Skip to main content
SpringerLink
Log in

Klinisches Staging der Peritonealkarzinose durch Scoringsysteme

Eine kritische Analyse

Scoring systems for clinical staging of peritoneal carcinomatosis

A critical analysis

  • Leitthema
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Im Rahmen des klinischen Stagings zur Beschreibung des Umfangs einer Peritonealkarzinose, der bei zytoreduktiver Chirurgie notwendigen Maßnahmen und des erzielten Ergebnisses in Form der Vollständigkeit der chirurgischen Zytoreduktion stehen unterschiedliche Klassifikations- und Scoringsysteme zur Verfügung. Die höchste klinische Relevanz bei der Peritonealkarzinose gastrointestinaler Tumoren haben Klassifikationen zur Tumorausdehnung und zur Vollständigkeit der chirurgischen Tumorresektion. Zumeist erfolgt eine Zuordnung der Patienten in die entsprechenden Stadien aufgrund der intraoperativen Evaluation und ist daher subjektiv. Die unterschiedlichen Klassifikationen werden dargestellt und hinsichtlich ihrer Anwendbarkeit, Genauigkeit und ihrer Wertigkeit als Selektionsinstrument sowie ihrer Aussagefähigkeit zur Prognose diskutiert und verglichen.

Abstract

For peritoneal carcinomatosis, several different classification and scoring systems for clinical staging have been proposed and used by the different centers worldwide engaged in treating this clinical entity. Of highest clinical relevance are the classifications assessing tumor distribution and size and those describing the degree of surgical cytoreduction. Allocation of patients to different stages is based on clinical intraoperative evaluation and therefore is subjective and observer-dependent. The various classification systems are presented and discussed regarding applicability, exactness, and their value as either selection criterion or prognostic instrument.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6: 727–731

    Article  PubMed  CAS  Google Scholar 

  2. Elias D, Sideris L, Pocard M et al. (2004) Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 15: 781–785

    Article  PubMed  CAS  Google Scholar 

  3. Beaujard AC, Glehen O, Caillot JL et al. (2000) Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88: 2512–2519

    Article  PubMed  CAS  Google Scholar 

  4. Carmignani CP, Sugarbaker PH (2004) Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer. Eur J Surg Oncol 30: 864–868

    Article  PubMed  Google Scholar 

  5. Cavaliere F, Perri P, Di Filippo F et al. (2000) Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 74: 41–44

    Article  PubMed  CAS  Google Scholar 

  6. Ceelen WP, Hesse U, Hemptinne B de, Pattyn P (2000) Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 87: 1006–1015

    Article  PubMed  CAS  Google Scholar 

  7. Bree E de, Koops W, Kröger R et al. (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86: 64–73

    Article  PubMed  Google Scholar 

  8. Bree E de, Koops W, Kröger R et al. (2006) Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32: 65–71

    Article  PubMed  Google Scholar 

  9. Elias D, Blot F, El Otmany A et al. (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92: 71–76

    Article  PubMed  CAS  Google Scholar 

  10. Glehen O, Cotte E, Schreiber V et al. (2004) Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91: 747–754

    Article  PubMed  CAS  Google Scholar 

  11. Glehen O, Kwiatkowski F, Sugarbaker PH et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22: 3284–3292

    Article  PubMed  CAS  Google Scholar 

  12. Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5: 219–228

    Article  PubMed  Google Scholar 

  13. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal Carcinomatosis: Principles of Management. Kluwer Academic Publishers, Boston, pp 359–374

  14. Deraco M, Baratti D, Inglese MG et al. Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP) (2004) A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11: 393–398

    Article  PubMed  Google Scholar 

  15. Ahmad SA, Kim J, Sussman JJ et al. (2004) Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol 11: 387–392

    Article  PubMed  Google Scholar 

  16. Elias D, Matsuhisa T, Sideris L et al. (2004) Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 15: 1558–1565

    Article  PubMed  CAS  Google Scholar 

  17. Glehen O, Mohamed F, Sugarbaker PH (2004) Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 240: 278–285

    Article  PubMed  Google Scholar 

  18. Miner TJ, Shia J, Jaques DP et al. (2005) Long-term survival following treatment of pseudomyxoma peritonei. Ann Surg 241: 300–308

    Article  PubMed  Google Scholar 

  19. Shen P, Hawksworth J, Lovato J et al. (2004) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11: 178–186

    Article  PubMed  Google Scholar 

  20. Verwaal VJ, Boot H, Aleman BMP et al. (2004) Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: Location, treatment, and outcome. Ann Surg Oncol 11: 375–379

    Article  PubMed  Google Scholar 

  21. Yan TD, Haveric N, Carmignani CP et al. (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103: 839–849

    Article  PubMed  Google Scholar 

  22. Pestieau SR, Sugarbaker PH (2000) Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant versus delayed management. Dis Colon Rectum 43: 1341–1346

    Article  PubMed  CAS  Google Scholar 

  23. Younan R, Kusamura S, Baratti D et al. (2005) Complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 12: 910–918

    Article  PubMed  Google Scholar 

  24. Glehen O, Gilly FN (2003) Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 12: 649–671

    Article  PubMed  Google Scholar 

  25. Japanese research society for gastric cancer (1981) The general rules for the gastric cancer study in surgery and pathology. Japn J Surg 11: 127–139

    Article  Google Scholar 

  26. Gilly FN, Carry PY, Sayag AC (1994) Regional chemotherapy with mitomycin C and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41: 124–129

    PubMed  CAS  Google Scholar 

  27. Jacquet P, Sugarbaker PH (1996) Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15: 49–58

    Google Scholar 

  28. Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2: 3

    Article  PubMed  Google Scholar 

  29. Tentes AAK, Tripsiannis G, Markakidis SK et al. (2003) Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29: 69–73

    Article  PubMed  Google Scholar 

  30. Verwaal VJ, Tinteren H van, Ruth S van, Zoetmulder FAN (2004) Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 91: 739–746

    Article  PubMed  CAS  Google Scholar 

  31. Yan TD, Haveric N, Carmignani CP et al. (2005) Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 91: 394–400

    PubMed  Google Scholar 

  32. Verwaal VJ, Ruth S van, Bree E de et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21: 3737–3743

    Article  PubMed  Google Scholar 

  33. Fujimoto S, Takahashi M, Mutou T et al. (1997) Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79: 884–891

    Article  PubMed  CAS  Google Scholar 

  34. Kusamura S, Younan R, Dario Baratti D et al.(2006) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion. Cancer 106: 1144–1153

    Article  PubMed  Google Scholar 

  35. Loungnarath R, Causeret S, Bossard N et al. (2005) Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: A prospective study. Dis Colon Rectum 48: 1372–1379

    Article  PubMed  Google Scholar 

  36. Mahteme H, Sugarbaker PH (2004) Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg 91: 1168–1173

    Article  PubMed  CAS  Google Scholar 

  37. Nonaka D, Kusamura S, Baratti D et al. (2005) Diffuse malignant mesothelioma of the peritoneum. Cancer 104: 2181–2188

    Article  PubMed  Google Scholar 

  38. Pestieau SR, Jelinek JS, Chang D et al. (2000) CT in the selection of patients with abdominal or pelvic sarcoma for reoperative surgery. J Am Coll Surg 190: 700–710

    Article  PubMed  CAS  Google Scholar 

  39. Portilla AG, Sugarbaker PH, Chang D (1999) Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognostic features. World J Surg 23: 23–29

    Article  PubMed  CAS  Google Scholar 

  40. Sebbag G, Yan H, Shmookler M et al. (2000) Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87: 1587–1593

    Article  PubMed  CAS  Google Scholar 

  41. Sugarbaker PH (2002) Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Semin Oncol 29: 51–61

    Article  PubMed  Google Scholar 

  42. Shen P, Levine EA, Hall J et al. (2003) Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138: 26–33

    Article  PubMed  CAS  Google Scholar 

  43. Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol Suppl 43: S15–S25

    Article  Google Scholar 

  44. Loggie BW, Fleming RA, McQuellon RP et al. (2000) Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 66: 561–568

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik für Allgemein- und Viszeralchirurgie, Schwerpunkt für endokrine und onkologische Chirurgie , Diakoniekrankenhaus Henriettenstiftung gGmbH, Marienstraße 72–90, 30171, Hannover, Deutschland

    J. Jähne & S. Kübler

Authors
  1. J. Jähne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Kübler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Jähne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jähne, J., Kübler, S. Klinisches Staging der Peritonealkarzinose durch Scoringsysteme. Chirurg 78, 1091–1099 (2007). https://doi.org/10.1007/s00104-007-1426-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-007-1426-1

Schlüsselwörter

Keywords

Search

Navigation